CNS Pharmaceuticals, Inc. CNSP
Set alert
5.00 USD +0.23 +4.82%
At close · Oct 30
5.00 0.00 0.00%
After hours · Oct 30, 4:00 PM ET
4.25 Day range 5.00
2.13 52-week range 7.84
- YTD
- -4.76%
- 1 year
- -33.42%
- Open
- 4.60
- Prev close
- 4.77
- Mkt cap
- 7.31M
- Vol
- 52.92K
- Avg vol
- 8.37K
- EPS
- -17.90
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 4.25
- High
- 5.00
- Forward P/E
- -0.28
- Beta
- 1.05
- Short ratio
- 0.04
- Inst. own
- 0.79%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 0.11872
- 200-d avg
- 4.42
- 1y target
- 0.50
Financial health
Altman Z-Score
-7.22 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C+2 / 5 overall
- DCF 5
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 4
Valuation
P/E -0.1×
FY 2017 5y median -0.2× FY 2025
P/S 0.0×
FY 2017 5y median 0.0× FY 2025
P/B 0.5×
FY 2017 5y median 0.4× FY 2025
P/FCF -0.2×
FY 2017 5y median -0.3× FY 2025
EV/EBITDA 0.3×
FY 2017 5y median 0.3× FY 2025
EV/Sales 0.0×
FY 2017 5y median 0.0× FY 2025
FCF Yield -594.1%
FY 2017 5y median -326.0% FY 2025
Profitability
Gross Margin 0.0%
FY 2017 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2017 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2017 5y median 0.0% FY 2025
ROE -350.5%
FY 2017 5y median -218.9% FY 2025
ROIC -329.5%
FY 2017 5y median -206.7% FY 2025
ROA -183.8%
FY 2017 5y median -170.8% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2017 FY 2025
Operating Income -7.3%
FY 2017 FY 2025
EPS (diluted) 92.3%
FY 2017 FY 2025
Free Cash Flow 19.2%
FY 2017 FY 2025
Financial Health
Current Ratio 2.0×
FY 2017 5y median 2.6× FY 2025
Quick Ratio 2.0×
FY 2017 5y median 2.6× FY 2025
Debt / Equity 0.1×
FY 2017 5y median 0.1× FY 2025
Net Debt / EBITDA 0.4×
FY 2017 5y median 0.4× FY 2025
Interest Coverage -1050×
FY 2017 5y median -1367× FY 2025
Dividends
Dividend Yield 0.0%
FY 2017 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2017 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31